20/03/2023
Published by Fondazione Gianni Bonadonna at 20/03/2023
Categories

Dabrafenib and trametinib in anaplastic advanced thyroid cancer

Do you like it?0
Read more
13/03/2023
Published by Fondazione Gianni Bonadonna at 13/03/2023
Categories

Mediterranean diet could improve efficacy of immunotherapy in advanced melanoma

Do you like it?0
Read more
06/03/2023
Published by Fondazione Gianni Bonadonna at 06/03/2023
Categories

Olaparib in BRCA-mutated, HER-2 negative metastatic breast cancer

Do you like it?0
Read more
27/02/2023
Published by Fondazione Gianni Bonadonna at 27/02/2023
Categories

Avelumab added to chemotherapy in advanced or recurrent endometrial cancer

Do you like it?0
Read more
20/02/2023
Published by Fondazione Gianni Bonadonna at 20/02/2023
Categories

Trastuzumab deruxtecan in advanced gastric tumors

Do you like it?0
Read more
13/02/2023
Published by Fondazione Gianni Bonadonna at 13/02/2023
Categories

A young hematologist and researcher is awarded a Fellowship in the second edition of the Call dedicated to the memory of Gianni Bonadonna

Do you like it?0
Read more
06/02/2023
Published by Fondazione Gianni Bonadonna at 06/02/2023
Categories

Federated learning to predicting chemotherapy response in triple-negative breast cancer

Do you like it?0
Read more
30/01/2023
Published by Fondazione Gianni Bonadonna at 30/01/2023
Categories

Clinical benefits with futibatinib in intra-hepatic cholangiocarcinoma

Do you like it?0
Read more
23/01/2023
Published by Fondazione Gianni Bonadonna at 23/01/2023
Categories

PARP inhibitors in advanced prostate cancer, determining HRR genes alterations is crucial for outcomes

Do you like it?0
Read more
1234567891011
Next page